Gel permeation methods have been commonly used to screen combinatorial libraries synthesized on a solid support. We report here three screens of combinatorial libraries using gel permeation assays. These include a simple enzymatic assay to identify inhibitors of the influenza enzyme neuraminidase, and two more complex assays designed to screen for inhibitors of the interleukin-8 (IL-8)-IL-8 receptor and the urokinase-urokinase receptor interactions, respectively. The IL-8 ligand-receptor assay makes use of IL-8 receptor-expressing cells attached to a membrane, thus enabling washing steps as part of the assay. The urokinase ligand-receptor assay employs an enzyme-linked immunosorbent assay-type format, previously thought to be amenable only to well-based assays. The results of these three screens are reported here, including the discovery of a novel series of acyclic inhibitors of neuraminidase. The development of complex assays in a gel permeation format allows for the routine screening of combinatorially as well as noncombinatorially made compound collections against virtually any kind of target, and is being widely used in our high throughput screening operations.
References
1.
Beutel BA: Discovery and identification of lead compounds from combinatorial mixtures. Ann Rep Med Chem1997;32:261-267.
2.
Beutel BA: Strategies for screening combinatorial libraries. In Gordon EM, Kerwin JF (eds): Combinatorial Chemistry and Molecular Diversity in Drug Discovery. New York: Wiley-Liss Inc., 1998:421-432.
3.
Sigal NH, Chelsky D: Approaches and technologies for screening large combinatorial libraries. In Gordon EM, Kerwin JF (eds): Combinatorial Chemistry and Molecular Diversity in Drug Discovery. New York: Wiley-Liss Inc., 1998:433-443.
4.
Jayawickreme CK, Graminski GF, Quillan JM, et al: Creation and functional screening of a multi-use peptide library. Proc Natl Acad Sci U S A1994;91:1614-1618.
5.
Quillan JM, Jayawickreme CK, Lerner MR: Combinatorial diffusion assay used to identify topically active melanocyte-stimulating hormone receptor antagonists. Proc Natl Acad Sci U S A1995;92:2894-2898.
6.
Salmon SE, Liu-Stevens RH, Zhao Y, et al: High-volume cellular screening for anticancer agents with combinatorial chemical libraries: a new methodology. Mol Diversity1996;2:57-63.
7.
Burbaum JJ, Sigal NH: New technologies for high-throughput screening. Curr Opin Chem Biol1997;1:72-78.
8.
Furka A: History of combinatorial chemistry. Drug Dev Res1995;36:1-12.
9.
Rinnova M, Lebl M: Molecular diversity and libraries of structures: synthesis and screening. Collect Czech Chem Commun1996;61:172-231.
10.
Lam KS, Lebl M, Krchndk V: The "one-bead-one-compound" combinatorial library method. Chem Rev1997;97:411-448.
11.
Brown BB, Wagner DS, Geysen HM: A single-bead decode strategy using electrospray ionization mass spectrometry and a new photolabile linker: 3-amino-3-(2-nitrophenyl)propionic acid. Mol Diversity1995;1:4-12.
12.
Gao L, Cheng X, Voorbach M, et al: Combinatorial library analysis using Fourier transform mass spectrometry (FTMS and tandem mass spectrometry (MS/MS)). In Proceedings of the 46th ASMS Conference on Mass Spectrometry and Allied Topics. American Society for Mass Spectrometry, Orlando, FL, May 31-June 4, 1998:1050.
13.
Wang GT, Chen Y, Gentles R, et al: Designing, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores. J Med Chem2001;44:1192-1201.
14.
McKimm-Breschkin JL: Resistance of influenza viruses to neuraminidase inhibitors a review. Antiviral Res2000;47:1-17.
15.
Burbaum JJ, Ohlmeyer MHJ, Reader JC, et al: A paradigm for drug discovery employing encoded combinatorial libraries. Proc Natl Acad Sci U S A1995;92:6027-6031.
16.
Beutel BA, Schurdak ME, Voorbach MJ, et al: Continuous Format High Throughput Screening. U.S. Patent 5,976,813, 1999.
17.
Burns DJ, Kofron JL, Warrior U, et al: Well-less, gel permeation format for ultra-high throughput screening. Drug Discov Today HTS Suppl2001;6:S144-S151.
18.
Karet G: More compounds tested with less automation. Drug Discov Dev2000;June/July:48-51.
